News

SPINEART SECURES MORE THAN CHF20 MILLION IN CONVERTIBLE FINANCING FOLLOWING COMPLETION OF BAGUERA® C IDE STUDIES ENROLLMENT

SPINEART COMPLETES ENROLLMENT IN THE BAGUERA®C IDE TRIAL FOR TWO-LEVEL CERVICAL DISC REPLACEMENT

SPINEART COMPLETES ENROLLMENT IN THE BAGUERA®C IDE TRIAL FOR SINGLE-LEVEL CERVICAL DISC REPLACEMENT

SOLCO BIOMEDICAL HAS BEEN OFFICIALLY APPOINTED AS OUR NEW EXCLUSIVE DISTRIBUTOR FOR BAGUERA® C IN THE REPUBLIC OF KOREA.

GROUNDBREAKING CEREMONY OF OUR NEW FACTORY!

SPINEART HAS REACHED AND SURPASSED THE €100M OF REVENUE.